within Pharmacolibrary.Drugs.ATC.B;

model B01AE01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 15 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B01AE01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Desirudin is a recombinant hirudin, a direct thrombin inhibitor used for prophylaxis of deep vein thrombosis (DVT) in patients undergoing elective hip replacement surgery. It acts by inhibiting free and clot-bound thrombin. Desirudin is approved for medical use but is not widely available in all countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adults after subcutaneous administration.</p><h4>References</h4><ol><li><p>Graetz, TJ, et al., &amp; Avidan, MS (2011). Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis. <i>Expert review of cardiovascular therapy</i> 9(9) 1101–1109. DOI:<a href=&quot;https://doi.org/10.1586/erc.11.131&quot;>10.1586/erc.11.131</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21932952/&quot;>https://pubmed.ncbi.nlm.nih.gov/21932952</a></p></li><li><p>Maan, A, et al., &amp; Heist, EK (2012). Newer anticoagulants in cardiovascular disease: a systematic review of the literature. <i>Cardiology in review</i> 20(5) 209–221. DOI:<a href=&quot;https://doi.org/10.1097/CRD.0b013e3182503e2d&quot;>10.1097/CRD.0b013e3182503e2d</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22370770/&quot;>https://pubmed.ncbi.nlm.nih.gov/22370770</a></p></li><li><p>Nafziger, AN, &amp; Bertino, JS (2010). Desirudin dosing and monitoring in moderate renal impairment. <i>Journal of clinical pharmacology</i> 50(6) 614–622. DOI:<a href=&quot;https://doi.org/10.1177/0091270009350626&quot;>10.1177/0091270009350626</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19915180/&quot;>https://pubmed.ncbi.nlm.nih.gov/19915180</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B01AE01;
